Tempest Therapeutics, Inc.
TPST
$6.87
$0.385.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.85% | -10.30% | -21.08% | -5.56% | -10.34% |
| Total Depreciation and Amortization | -49.48% | -37.42% | 76.14% | 3.53% | -3.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.06% | -5.26% | -4.16% | 14.89% | 52.38% |
| Change in Net Operating Assets | 245.01% | -162.62% | 285.11% | -242.57% | 58.17% |
| Cash from Operations | 0.32% | -84.79% | 23.32% | -16.37% | 4.81% |
| Capital Expenditure | 80.00% | 93.98% | -48.21% | -2,300.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 80.00% | 93.98% | -48.21% | -2,300.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -- | -- | -- | -- |
| Issuance of Common Stock | 438.80% | -17.93% | 912.67% | -98.69% | 163,466.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,064.96% | -66.18% | 912.67% | -98.69% | 163,466.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 190.11% | -620.13% | 82.59% | -124.51% | 535.62% |